Changes in urine microalbumin-to-creatinine ratio in children with sickle cell disease over time

Frontiers in Pediatrics

Volumn 4, Issue OCT, 2016, Pages

  Shatat, Ibrahim F ^a,b,c   Qanungo, Suparna ^b   Hudson, Shannon ^b   Laken, Marilyn A ^b   Hailpern, Susan M ^d  

^a SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d Independent Epidemiology Consultant   (United States)

Author keywords

Children; Microalbuminuria; Progression; Sickle cell nephropathy; Young adults

Indexed keywords

EID: 85026833449     PISSN: None     EISSN: 22962360     Source Type: Journal    
DOI: 10.3389/fped.2016.00106     Document Type: Article

References (32)

1. Wesson DE. The initiation and progression of sickle cell nephropathy. Kidney Int (2002) 61:2277-86. doi:10.1046/j.1523-1755.2002.00363.x
2. Keen H, Chlouverakis C, Fuller J, Jarrett RJ. The concomitants of raised blood sugar: studies in newly-detected hyperglycaemics: II. Urinary albumin excretion, blood pressure and their relation to blood sugar levels. Int J Epidemiol (2014) 43:11-5. doi:10.1093/ije/dyt257
3. Wachtell K, Palmieri V, Olsen MH, Bella JN, Aalto T, Dahlöf B, et al. Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. Am Heart J (2002) 143:319-26. doi:10.1067/mhj.2002.119895
4. Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol (2009) 20:1813-21. doi:10.1681/ASN.2008121270
5. van der Velde M, Halbesma N, de Charro FT, Bakker SJ, de Zeeuw D, de Jong PE, et al. Screening for albuminuria identifies individuals at increased renal risk. J Am Soc Nephrol (2009) 20:852-62. doi:10.1681/ASN.2008060655
6. Powars DR, Elliott-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, et al. Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med (1991) 115:614-20. doi:10.7326/0003-4819-115-8-614
7. Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (2005) 84:363-76. doi:10.1097/01.md.0000189089.45003.52
8. Alvarez O, Lopez-Mitnik G, Zilleruelo G. Short-term follow-up of patients with sickle cell disease and albuminuria. Pediatr Blood Cancer (2008) 50:1236-9. doi:10.1002/pbc.21520
9. McKie KT, Hanevold CD, Hernandez C, Waller JL, Ortiz L, McKie KM. Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease. J Pediatr Hematol Oncol (2007) 29:140-4. doi:10.1097/MPH.0b013e3180335081
10. Becton LJ, Kalpatthi RV, Rackoff E, Disco D, Orak JK, Jackson SM, et al. Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease. Pediatr Nephrol (2010) 25:1505-11. doi:10.1007/s00467-010-1536-8
11. Datta V, Ayengar JR, Karpate S, Chaturvedi P. Microalbuminuria as a predictor of early glomerular injury in children with sickle cell disease. Indian J Pediatr (2003) 70:307-9. doi:10.1007/BF02723586
12. McBurney PG, Hanevold CD, Hernandez CM, Waller JL, McKie KM. Risk factors for microalbuminuria in children with sickle cell anemia. J Pediatr Hematol Oncol (2002) 24:473-7. doi:10.1097/00043426-200208000-00013
13. Ranque B, Menet A, Diop IB, Thiam MM, Diallo D, Diop S, et al. Early renal damage in patients with sickle cell disease in sub-Saharan Africa: a multinational, prospective, cross-sectional study. Lancet Haematol (2014) 1(2):e64-73. doi:10.1016/S2352-3026(14)00007-6
14. de Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol (2006) 17:2100-5. doi:10.1681/ASN.2006050517
15. Bank N, Kiroycheva M, Ahmed F, Anthony GM, Fabry ME, Nagel RL, et al. Peroxynitrite formation and apoptosis in transgenic sickle cell mouse kidneys. Kidney Int (1998) 54:1520-8. doi:10.1046/j.1523-1755.1998.00148.x
16. Falk RJ, Scheinman J, Phillips G, Orringer E, Johnson A, Jennette JC. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med (1992) 326:910-5. doi:10.1056/NEJM199204023261402
17. Ataga KI, Derebail VK, Archer DR. The glomerulopathy of sickle cell disease. Am J Hematol (2014) 89:907-14. doi:10.1002/ajh.23762
18. Allon M, Lawson L, Eckman JR, Delaney V, Bourke E. Effects of nonsteroidal antiinflammatory drugs on renal function in sickle cell anemia. Kidney Int (1988) 34:500-6. doi:10.1038/ki.1988.209
19. Gosmanova EO, Zaidi S, Wan JY, Adams-Graves PE. Prevalence and progression of chronic kidney disease in adult patients with sickle cell disease. J Investig Med (2014) 62:804-7. doi:10.1097/01.JIM.0000446836.75352.72
20. Barratt TM, McLaine PN, Soothill JF. Albumin excretion as a measure of glomerular dysfunction in children. Arch Dis Child (1970) 45:496-501. doi:10.1136/adc.45.242.496
21. Gurkan S, Scarponi KJ, Hotchkiss H, Savage B, Drachtman R. Lactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia. Pediatr Nephrol (2010) 25:2123-7. doi:10.1007/s00467-010-1560-8
22. Lebensburger J, Johnson SM, Askenazi DJ, Rozario NL, Howard TH, Hilliard LM. Protective role of hemoglobin and fetal hemoglobin in early kidney disease for children with sickle cell anemia. Am J Hematol (2011) 86:430-2. doi:10.1002/ajh.21994
23. Dharnidharka VR, Dabbagh S, Atiyeh B, Simpson P, Sarnaik S. Prevalence of microalbuminuria in children with sickle cell disease. Pediatr Nephrol (1998) 12:475-8. doi:10.1007/s004670050491
24. Marsenic O, Couloures KG, Wiley JM. Proteinuria in children with sickle cell disease. Nephrol Dial Transplant (2008) 23:715-20. doi:10.1093/ndt/gfm858
25. Alvarez O, Montane B, Lopez G, Wilkinson J, Miller T. Early blood transfusions protect against microalbuminuria in children with sickle cell disease. Pediatr Blood Cancer (2006) 47:71-6. doi:10.1002/pbc.20645
26. Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA (2014) 312:1033-48. doi:10.1001/jama.2014.10517
27. Aygun B, Mortier NA, Smeltzer MP, Shulkin BL, Hankins JS, Ware RE. Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia. Am J Hematol (2013) 88:116-9. doi:10.1002/ajh.23365
28. Bartolucci P, Habibi A, Stehlé T, Di Liberto G, Rakotoson MG, Gellen-Dautremer J, et al. Six months of hydroxyurea reduces albuminuria in patients with sickle cell disease. J Am Soc Nephrol (2015) 27(6):1847-53. doi:10.1681/ASN.2014111126
29. Voskaridou E, Terpos E, Michail S, Hantzi E, Anagnostopoulos A, Margeli A, et al. Early markers of renal dysfunction in patients with sickle cell/beta-thalassemia. Kidney Int (2006) 69:2037-42. doi:10.1038/sj.ki.5000248
30. Fitzhugh CD, Wigfall DR, Ware RE. Enalapril and hydroxyurea therapy for children with sickle nephropathy. Pediatr Blood Cancer (2005) 45:982-5. doi:10.1002/pbc.20296
31. Aoki RY, Saad ST. Enalapril reduces the albuminuria of patients with sickle cell disease. Am J Med (1995) 98:432-5. doi:10.1016/S0002-9343(99)80341-6
32. Foucan L, Bourhis V, Bangou J, Mérault L, Etienne-Julan M, Salmi RL. A randomized trial of captopril for microalbuminuria in normotensive adults with sickle cell anemia. Am J Med (1998) 104:339-42. doi:10.1016/S0002-9343(98)00056-4